The Drug development process - Pharmaceutical Biotechnology: Concepts and Aapplications - page 105

Streatfi eld, S. 2005. Regulatory issues for plant-made pharmaceuticals and vaccines. Expert Review of Vaccines
4 (4), 591- 601.
Tang, L., Persky, A.M., Hochhaus, G., and Meibohm, B. 2004. Pharmacokinetic aspects of biotechnology prod-
ucts. Journal of Pharmaceutical Sciences 93 (9), 2184-2204.
Walsh, G. 1999. Drug approval in Europe. Nature Biotechnology , 17 , 237-240.
Walsh, G. 2006. Drug approval in the European Union and United States. In An Introduction to Molecular
Biotechnology , Wink, M. (ed.). Wiley-VCH; pp. 651-662.
Drug delivery
Davis, S. 2001. Nasal vaccines. Advanced Drug Delivery Reviews 51 , 21-42.
Hamman, J.H., Enslin, G.M., and Kotzé, A.F. 2005. Oral delivery of peptide drugs - barriers and developments.
Biodrugs 19 (3), 165-177.
Kompella, U.B. and Lee, V.H.L. 2001. Delivery systems for penetration enhancement of peptide and protein
drugs: design considerations. Advanced Drug Delivery Reviews 46 , 211-245.
Hussain, A., Arnold, J.J., Khan, M.A., and Ahsan, F. 2004. Absorption enhancers in pulmonary drug delivery.
Journal of Controlled Release 94 (1), 15-24.
Orive, G., Hernandez, R.M., Gascon, A.R., Dominguez-Gil, A., and Pedraz, J.L. 2003. Drug delivery in biotech-
nology: present and future. Current Opinion in Biotechnology 14 (6), 659-664.
Patton, J. 1996. Mechanisms of macromolecule absorption by the lungs. Advanced Drug Delivery Reviews 19 ,
3-36.
Patton, J.S., Bukar, J.G., and Eldon, M.A. 2004. Clinical pharmacokinetics and pharmacodynamics of inhaled
insulin. Clinical Pharmacokinetics 43 (12), 781-801.
Quattrin, T. 2004. Inhaled insulin: recent advances in the therapy of type 1 and 2 diabetes. Expert Opinion on
Pharmacotherapy . 5 (12), 2597-2604.
Shah, R.B., Ahsan, F., and Khan, M.A. 2002. Oral delivery of proteins: progress and prognostication. Critical
Reviews in Therapeutic Drug Carrier Systems 19 (2), 135-169.
Shaikh, I.M., Jadhav, K.R., Ganga, S., Kadam, V.J., and Pisal, S.S. 2005. Advanced approaches in insulin deliv-
ery. Current Pharmaceutical Biotechnology 6 (5), 387-395.
Veronese, F.M. and Pasut, G. 2005. PEGylation, successful approach to drug delivery. Drug Discovery Today
10 , 1451-1458.
Genomics, proteomics and related technologies
Baba, Y. 2001. Development of novel biomedicine based on genome science. European Journal of Pharmaceuti-
cal Sciences 13 (1), 3- 4.
Brenner, S. 2001. A tour of structural genomics. Nature Reviews Genetics 2 (10), 801-809.
Cunningham, M. 2000. Genomics and proteomics, the new millennium of drug discovery and development.
Journal of Pharmacological and Toxicological Methods 44 (1), 291-300.
Debouck, C. and Goodfellow, P. 1999. DNA microarrays in drug discovery and development. Nature Genetics
21 , 48-50.
Gabig, M. and Wegrzyn, G. 2001. An introduction to DNA chips: principles, technology, applications and
analysis. Acta Biochimica Polonica 48 (3), 615-622.
Jain, K. 2001. Proteomics: new technologies and their applications. Drug Discovery Today 6 (9), 457-459.
Jain, K. 2001. Proteomics: delivering new routes to drug discovery, part 2. Drug Discovery Today . 6 (16),
829-832.